U.S. markets closed

Orange County Bancorp, Inc. (OBT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
38.53+1.92 (+5.26%)
At close: 04:00PM EST
38.75 0.00 (0.00%)
After hours: 04:01PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Down

Gap Down

Previous Close36.61
Bid28.80 x 2900
Ask38.75 x 1100
Day's Range38.53 - 38.75
52 Week Range25.50 - 41.00
Avg. Volume5,811
Market Cap217.236M
Beta (5Y Monthly)0.44
PE Ratio (TTM)9.40
EPS (TTM)4.10
Earnings DateN/A
Forward Dividend & Yield0.80 (2.28%)
Ex-Dividend DateDec 02, 2021
1y Target Est42.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
76% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for OBT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Orange County Bancorp, Inc.
    Analyst Report: Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has four drugs on the market: Onpattro for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. The firm also has 12 clinical programs across the following therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Additionally, up-front fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
    Fair Value
    Economic Moat
    9 days agoMorningstar
View more

    Orange Bank and Trust Company Opens New Full-Service Branch in Nanuet

    MIDDLETOWN, NY / ACCESSWIRE / November 22, 2021 / The Board of Directors and CEO Michael Gilfeather of Orange Bank & Trust Company proudly announce the opening of their second full-service banking office in Rockland County. Located at 374 South Middletown Road, the office will serve businesses, non-profits and municipalities in the southeastern Rockland County area.


    Orange County Bancorp, Inc. Declares Cash Dividend

    MIDDLETOWN, NY / ACCESSWIRE / November 19, 2021 / On November 19, 2021, the Board of Directors of Orange County Bancorp, Inc. (NASDAQ:OBT), the parent company of Orange Bank & Trust Company and Hudson Valley Investment Advisors, Inc.

  • Zacks

    What Makes Orange County Bancorp, Inc. (OBT) a Good Fit for "Trend Investing"

    Orange County Bancorp, Inc. (OBT) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.